Compass Therapeutics, Inc.
CMPXNASDAQHealthcare● Active
$2.02
$-0.02(-0.98%)
Market Cap$279338328
P/E Ratio—
52W High$6.88
52W Low$1.61
Compass Therapeutics, Inc. (CMPX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CMPX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.21B | $0.13B | $0.15B | $0.19B | $0.14B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.21B | $0.13B | $0.15B | $0.19B | $0.15B |
| PP&E Net | $0.01B | $0.01B | $0.00B | $0.00B | $0.01B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.22B | $0.14B | $0.16B | $0.20B | $0.15B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Long-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.02B | $0.02B | $0.01B | $0.02B | $0.01B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.43B) | ($0.36B) | ($0.32B) | ($0.27B) | ($0.23B) |
| Total Stockholders Equity | $0.20B | $0.13B | $0.15B | $0.18B | $0.14B |
| Total Liab & Equity(computed) | $0.22B | $0.14B | $0.16B | $0.20B | $0.15B |
| Debt Summary | |||||
| Total Debt | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Net Debt | ($0.02B) | ($0.04B) | ($0.02B) | ($0.03B) | ($0.14B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Compass Therapeutics, Inc. data
About Compass Therapeutics, Inc. (CMPX) Balance Sheet
Compass Therapeutics, Inc. (CMPX) balance sheet shows total assets of $0.22B with cash of $0.21B. Total liabilities are $0.02B, total debt $0.01B, and stockholders equity $0.20B.
Frequently asked questions
CMPX · 4 questionsCompass Therapeutics, Inc. has total debt of $0.01B with net debt of ($0.02B).
CMPX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10